The US Food and Drug Administration( FDA) declared the use of blood plasma from the recovered patients of Corona-virus as a safe treatment.
FDA breakthrough the decision when President Donald Trump blamed the agency for the delay due to political reasons.
A day before, Trump tweeted while addressing the agency’s Commissioner Stephen Hahn,
“The deep state, or whoever, over at the FDA is making it very difficult for drug companies to get people in order to test the vaccines and therapeutics. Obviously, they are hoping to delay the answer until after November 3rd. Must focus on speed, and saving lives!”
On Sunday, the announcement comes out as ”emergency use authorization” from FDA. It revealed at the time of the Republican National Convention, where Trump will be nominated to lead his party for four more years.
Then the Republican president Trump at a White House news briefing stated,
“Everybody working together, we are years ahead of approvals than we would be if we went by the speed levels of the past administration,”
He further added,
“You’ll be hearing very soon about treatments and vaccines to save lives. We’re removing unnecessary barriers and delays, not by cutting corners, but by marshaling the full power of the federal government.”
Earlier, the FDA suggested that the use of blood plasma will help to improve the health of the patients after three days of hospitalization.
Peter Marks, director of the Food and Drug Administration’s Center for Biologic Evaluation and Research had a conference call with reporters. He said,
“It appeared that the product is safe and we’re comfortable with that and we continue to see no concerning safety signals.”
Evidence lag behind in US FDA corona-virus treatment
The FDA said the use of plasma is a safe approach as 70,000 patients have been recovered with it. Also, most of the benefited people were of age above 80 without any other respiratory issues. Recovered patients from blood plasma showed a 35% better survival rate after a month.
But so far, with no other health benefits with its use, some other health experts were doubtful,
Dr Amesh Adalja, a senior scholar at Johns Hopkins Center for Health Security said the move will hurt the response of the coronavirus treatment in the country.
The use of blood plasma is still under consequences. The reason is that there is no such data that shows the positive results of the treatment on patients. It will further examine trials to get the effective results of the benefits of this treatment via blood plasma.